CORDRAN Drug Patent Profile

Which patents cover Cordran, and what generic alternatives are available?

Cordran is a drug marketed by Ina Pharms, Almirall, and Lilly. and is included in five NDAs.

The generic ingredient in CORDRAN is flurandrenolide; neomycin sulfate. There are four drug master file entries for this compound. Additional details are available on the flurandrenolide; neomycin sulfate profile page.

Summary for CORDRAN

US Patents:	0
Applicants:	3
NDAs:	5
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	50
Patent Applications:	4,434
Drug Prices:	Drug price information for CORDRAN
What excipients (inactive ingredients) are in CORDRAN?	CORDRAN excipients list
DailyMed Link:	CORDRAN at DailyMed

See drug prices for CORDRAN

Pharmacology for CORDRAN

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for CORDRAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ina Pharms	CORDRAN	flurandrenolide	LOTION;TOPICAL	013790-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Ina Pharms	CORDRAN SP	flurandrenolide	CREAM;TOPICAL	012806-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Ina Pharms	CORDRAN SP	flurandrenolide	CREAM;TOPICAL	012806-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No

Expired US Patents for CORDRAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455-001	Approved Prior to Jan 1, 1982	3,632,740